Burden of migraine, impact of emerging therapies on managed care
from American Journal of Managed Care
Migraine is a highly prevalent neurological condition with substantial impact on individuals through associated complications, comorbidities and increased healthcare costs. The burden on society is likewise substantial via increased healthcare costs and greater indirect costs, such as lost productivity. Research about the pathophysiology of migraine has led to the introduction of a new class of drugs, calcitonin gene-related peptide inhibitors.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063